ZEAL
Zealand Sp ADR

357
Loading...
Loading...
News
all
press releases
Zealand Pharma shares leap after Wells Fargo’s new Buy coverage
Investing.com -- Wells Fargo has initiated coverage of Zealand Pharma (NASDAQ:ZEAL) with an Overweight rating and a DKK 650 price target, seeing the Danish biotech as poised to become “a key obesity player” thanks to its differentiated pipeline targeting the rapidly expanding weight loss market.
investing.com·3mo ago
News Placeholder
More News
News Placeholder
European pharmaceutical shares edge lower after Trump threatens 200% drug tariff
Investing.com - Shares of European drugmakers slipped on Wednesday after U.S. President Donald Trump said that tariffs of up to 200% on pharmaceutical imports could be coming "very soon."
investing.com·3mo ago
News Placeholder
Morgan Stanley upgrades Zealand Pharma to Buy on 'long-term obesity potential'
Investing.com -- Morgan Stanley upgraded its rating on Zealand Pharma (NASDAQ:ZEAL) shares to Overweight from Equal Weight, highlighting a “long-term obesity potential” unlocked by the company’s recent partnership with Roche (SIX:ROG).
investing.com·7mo ago
News Placeholder
Zealand Pharma, Roche have 2 best-in-class obesity assets, CEO tells Investing.com
Investing.com -- Zealand Pharma shares surged more than 41% on Wednesday after announcing a $5.3 billion licensing deal with Roche for its GLP-1 obesity therapy petrelintide. 
investing.com·7mo ago
News Placeholder
NovoNordisk stock falls on Roche-Zealand pact; Jefferies cuts target
Investing.com -- Novo Nordisk (CSE:NOVOb) (NYSE:NVO) shares slumped Wednesday after Roche (SIX:ROG) struck a $5.3 billion deal to acquire rights to an obesity treatment from Denmark’s Zealand Pharma A/S (CSE:ZELA).
investing.com·7mo ago
News Placeholder
Zealand Pharma stock falls loss widens, revenue declines
investing.com·8mo ago
News Placeholder
Total number of shares and voting rights in Zealand Pharma at March 31, 2024
Company announcement No. 21 / 2024 Total number of shares and voting rights in Zealand Pharma at March 31, 2024 Copenhagen, Denmark, March 31, 2024 Zealand Pharma A/S ( Zealand...
Globe Newswire·2y ago
News Placeholder
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement No. 20 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons...
Globe Newswire·2y ago
News Placeholder
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Company announcement No. 19 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 26, 2024 Zealand Pharma...
Globe Newswire·2y ago
News Placeholder
Zealand Pharma major shareholder announcement: Van Herk Investments
Company announcement No. 18 / 2024 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark, 21 March 2024 Zealand Pharma A/S ( Zealand ) (Nasdaq: ZEAL...
Globe Newswire·2y ago

Latest ZEAL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.